US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist
  • 1.560
  • -0.010-0.64%
Close Dec 20 16:00 ET
  • 1.550
  • -0.010-0.64%
Post 20:01 ET
41.38MMarket Cap-1.46P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gain Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 33.330K--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 6.000K--
--2024/Q20.000 / 240.000K--
--2024/Q10.000 / 90.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 33.330K--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 6.000K--
--2024/Q20.000 / 240.000K--
--2024/Q10.000 / 90.000K--

Unlock Free Earnings Estimates

Gain Therapeutics Earnings Reports

  • Gain Therapeutics | 8-K: Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update

    Nov 14 17:15 ET

  • Gain Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14 16:11 ET

  • Gain Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:57 ET

  • Gain Therapeutics | 8-K: Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update

    Aug 8 16:50 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 6, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data